Surmodics, Inc. ( SRDX) - Key Metrics
Stock symbol SRDX is outdated, potentially delisted? Maybe it is available on other exchange?
SRDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $2.07 | -$0.37 | $0.10 | $0.06 |
| 2025Q2 | $1.97 | -$0.36 | $0.07 | $0.04 |
| 2025Q1 | $2.10 | -$0.26 | -$0.55 | -$0.58 |
| 2024Q4 | $2.34 | -$0.24 | $0.26 | $0.22 |
| 2024Q3 | $2.14 | -$0.53 | -$0.14 | -$0.21 |
SRDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | -19.95 |
| 2025Q2 | ? | -20.92 |
| 2025Q1 | ? | -38.59 |
| 2024Q4 | ? | -39.88 |
| 2024Q3 | ? | -19.65 |
SRDX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q3 | 0.21% | ? |
| 2025Q2 | 0.14% | ? |
| 2025Q1 | -1.45% | ? |
| 2024Q4 | 0.57% | ? |
| 2024Q3 | -0.50% | ? |
SRDX
Price: $42.98
52 week price:
Earnings Per Share: -1.24 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 34922
Ebitda: 887000Market Capitalization: 614.6 million